Qube Research & Technologies LTD Alx Oncology Holdings Inc Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 146,977 shares of ALXO stock, worth $79,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,977
Previous 138,470
6.14%
Holding current value
$79,367
Previous $231,000
60.61%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALXO
# of Institutions
91Shares Held
35.3MCall Options Held
34KPut Options Held
36.9K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$5.24 Million6.44% of portfolio
-
Redmile Group, LLC San Francisco, CA3.64MShares$1.97 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$1.71 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$992,4780.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $22M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...